These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33252286)

  • 41. Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Allan V; Banerjee A; Shah AD; Patel R; Denaxas S; Casas JP; Hemingway H
    Heart; 2017 Feb; 103(3):210-218. PubMed ID: 27580623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Senoo K; Lane DA; Lip GY
    Int J Cardiol; 2015 Feb; 181():247-54. PubMed ID: 25528530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electronic Decision support for Improvement of Contemporary Therapy for Stroke Prevention.
    Chaturvedi S; Kelly AG; Prabhakaran S; Saposnik G; Lee L; Malik A; Boerman C; Serlin G; Mantero AM
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):569-573. PubMed ID: 30472172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
    Noseworthy PA; Yao X; Deshmukh AJ; Van Houten H; Sangaralingham LR; Siontis KC; Piccini JP; Asirvatham SJ; Friedman PA; Packer DL; Gersh BJ; Shah ND
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26541393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
    Wertheimer G; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
    Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    Hsu JC; Maddox TM; Kennedy K; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM
    J Am Coll Cardiol; 2016 Jun; 67(25):2913-23. PubMed ID: 27339487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study.
    Jaakkola S; Kiviniemi TO; Jaakkola J; Pouru JP; Nuotio I; Vasankari T; Hartikainen JEK; Airaksinen KEJ
    Ann Med; 2022 Dec; 54(1):1452-1458. PubMed ID: 35594342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
    O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
    J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
    Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
    Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP; Saba S; Zhang Y; Hernandez I
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis.
    Han L; Askari M; Altman RB; Schmitt SK; Fan J; Bentley JP; Narayan SM; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2019 Oct; 12(10):e005595. PubMed ID: 31610712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.
    Piccini JP; Xu H; Cox M; Matsouaka RA; Fonarow GC; Butler J; Curtis AB; Desai N; Fang M; McCabe PJ; Page Ii RL; Turakhia M; Russo AM; Knight BP; Sidhu M; Hurwitz JL; Ellenbogen KA; Lewis WR;
    Circulation; 2019 Mar; 139(12):1497-1506. PubMed ID: 30700141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Giehm-Reese M; Johansen MN; Kronborg MB; Jensen HK; Gerdes C; Kristensen J; Johannessen A; Jacobsen PK; Djurhuus MS; Hansen PS; Riahi S; Nielsen JC
    Int J Cardiol; 2021 Jun; 333():110-116. PubMed ID: 33647366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation.
    Quinn GR; Severdija ON; Chang Y; Singer DE
    Circulation; 2017 Jan; 135(3):208-219. PubMed ID: 27799272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.